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Abstract 
Age-related changes in brain structure result from a complex interplay between various 
neurobiological processes, which may contribute to more complex trajectories than can be 
described by simple linear or quadratic models. We used a non-parametric smoothing spline 
approach to delineate cross-sectionally estimated age-trajectories of the volume of 17 
neuroanatomical structures in 1100 healthy adults (18-94 years). Accelerated estimated 
decline in advanced age characterized some structures, e.g. hippocampus, but was not the 
norm. For most areas, one or two critical ages were identified, characterized by changes in 
the estimated rate of change. One year follow up data from 142 healthy older adults (60-91 
years) confirmed the existence of estimated change from the cross-sectional analyses for all 
areas except one (caudate). The cross-sectional and the longitudinal analyses agreed well on 
the rank order of age effects on specific brain structures (Spearman´s ρ = .91). The main 
conclusions are that most brain structures do not follow a simple path throughout adult life, 
and that accelerated decline in high age is not the norm of healthy brain aging. 
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1. Introduction 
The volume of most brain structures shrinks with age, but the degree of change is highly 
heterogeneous across different structures (Allen et al., 2005, Raz and Rodrigue, 2006). Also, 
age-related changes result from a complex interplay between various neurobiological 
processes, which is likely to have different impact in different phases of life. This is likely to 
produce more complex trajectories than what can be described by linear or the usually 
employed higher order polynomial (quadratic or even cubic) models (Fjell et al., 2010a). The 
present study was undertaken with the purpose of estimating trajectories across age of 17 
brain structures in a large cross-sectional sample (n = 1100). Parts of these data have been 
previously published (e.g. Fjell et al., 2009c), and we now re-analyze them by applying a 
statistical approach (the smoothing spline) sensitive to local changes in estimated rate of 
change (Fjell et al., 2010a). This makes it possible to identify critical ages where life-phases 
characterized by relative stability are followed by periods where estimated atrophy 
accelerates, or critical ages where periods of estimated reduction eventually level off. The 
cross-sectional results were compared with longitudinal atrophy rates from a sample of 142 
healthy elderly drawn from the Alzheimer Disease Neuroimaging Initiative (ADNI) (previously 
presented in (Fjell et al., 2009a)). 
 
Previous literature, including reports based on samples overlapping the present, indicates 
inverse U-shaped trajectories for hippocampus, cerebral WM, cerebellum WM and the brain 
stem (Allen et al., 2005, Walhovd et al., 2011, Lupien et al., 2007), while U and J-forms have 
been reported for caudate and the ventricular system (Sullivan et al., 1995, Good et al., 
2001, Walhovd et al., 2011). In contrast, mainly linear trajectories have been reported for 
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amygdala, thalamus, accumbens and putamen (Gunning-Dixon et al., 1998, Jernigan et al., 
2001a, Raz et al., 2003, Sullivan et al., 2004, Allen et al., 2005, Alexander et al., 2006, 
Nunnemann et al., 2007, Abe et al., 2008, Greenberg et al., 2008, Curiati et al., 2009, 
Walhovd et al., 2011). Both linear and quadratic reductions have been found for pallidum 
(Abe et al., 2008, Walhovd et al., 2011). The rational for the present study was to go beyond 
these general trends, by more accurately delineating the trajectories for the different 
structures across adult life, and to identify critical ages characterized by changes in 
estimated rate of atrophy. We included volume for 17 major regions and structures 
estimated from the whole-brain segmentation approach in FreeSurfer (Fischl et al., 2002). 
Surface-based cortical thickness results were presented in a previous publication (Fjell et al., 
in press). 
 
2. Materials and Methods 
2.1 Samples 
2.1.1 Cross-sectional sample: 1100 healthy adults (424 men/ 676 women), with an age range 
of 76 years (18-94 years, mean = 48, SD = 20) were included, pooled from five independent 
studies. Distribution of participants across decades are shown in Table 1. All the healthy 
samples were screened for diseases and history of neurological conditions and dementia, 
and none of the participants showed signs of cognitive dysfunction. The details of each of 
the subsamples are described in Supplementary Table 1, but a brief description is provided 
here: Sample 1 (Walhovd et al., 2005), n = 69, age 20-88 years (mean 51.3); Sample 2 
(Espeseth et al., 2008), n = 208, 19-75 years (mean 46.8); Sample 3 is from the Open Access 
Series of Imaging Studies(www.oasis-brains.org, Marcus et al., 2007), n = 309, 18-94 years 
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(44.5); Sample 4 (Raz et al., 2004a), n = 191, 18-81 years (47.3); Sample 5 (Fjell et al., 2010; 
Westlye et al., 2010), n = 323, 20-85 years (50.8).  
 
[Insert Table 1 about here] 
 
2.1.2 Longitudinal sample: The longitudinal sample consisted of 142 (60-90 years, mean age 
= 75.6 years, 48% females) participants from the Alzheimer Disease Neuroimaging Initiative 
(ADNI) database (www.loni.ucla.edu/ADNI), followed for one year. The raw data were 
obtained from the ADNI database, Principal Investigator Michael W. Weiner, VA Medical 
Center and University of California – San Francisco. The sample is identical to that included in 
a previous publication (Fjell et al., 2009a), and is included to allow direct statistical 
comparisons with the cross-sectional results. ADNI eligibility criteria are described at 
http://www.adni-info.org/index.php?option=com_content&task=view&id=9&Itemid=43.  
 
2.2 MRI processing 
All scans were obtained from 1.5T magnets from two different manufacturers (Siemens, 
Erlangen, Germany; General Electric CO, Milwaukee, WI), and from five different models 
(Siemens: Avanto, Symphony, Sonata, Vision/ GE: Signa). All participants within each sample 
were scanned on the same scanner. For details of the sequences, please consult Fjell et al. 
(Fjell et al., 2009b).  
 
Cross-sectional data were processed and analysed with FreeSurfer 4.01 
(http://surfer.nmr.mgh.harvard.edu/)(Fischl et al., 2002). A neuroanatomical label is 
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automatically assigned to each voxel in an MRI volume based on probabilistic information 
automatically estimated from a manually labeled training set (Fischl et al., 2002). The 
training set included both healthy persons in the age range 18-87 yrs and a group of 
Alzheimer's disease patients in the age range 60-87 yrs, and the classification technique 
employs a registration procedure that is robust to anatomical variability, including the 
ventricular enlargement typically associated with aging. The technique has previously been 
shown to be comparable in accuracy to manual labeling (Fischl et al., 2002; Fischl et al., 
2004). An atlas-based normalization procedure was used, shown to increase the robustness 
and accuracy of the segmentations across scanner platforms (Han and Fischl, 2007). For 
samples 1, 2, 3 and 5, 2-4 MPRAGEs were averaged before pre-processing to increase signal-
to-noise (SNR) and contrast-to-noise ratio (CNR). The following structures/ areas were 
included in the analyses: total brain volume (TBV), cerebral cortex and white matter (WM), 
hippocampus, amygdale, pallidum, caudate, putamen, thalamus, accumbens, brain stem, 
cerebellum cortex and WM, lateral ventricles, inferior lateral ventricles, 3rd ventricle and 4th 
ventricle. All segmentations were manually inspected for accuracy by an experienced 
operator, and corrected in case of errors. Minor manual edits were performed on most 
participants (> 80%), usually restricted to removal of non-brain tissue, typically dura/ vessels 
adjacent to the cortex. Additionally, presence of local artefacts sometimes caused small 
parts of WM to be segmented as GM. Such errors were routinely corrected. For 21 
participants, the final segmentations were judged to be of insufficient quality, and these 
were thus excluded from all analyses, reducing the sample from an initial 1121 to the 
reported 1100. 
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Intracranial volume (ICV) was estimated by use of an atlas-based normalization procedure, 
where the atlas scaling factor is used as a proxy for ICV, shown to correlate highly with 
manually derived ICV (r = .93) (Buckner et al., 2004). In a previous publications with an 
overlapping sample pool, the results for the pooled samples were replicable in each of the 
subsamples (Fjell et al., 2009b, Walhovd et al., 2011), indicating that the sensitivity of 
detecting effects are upheld and the statistical power are increased manifold. Thus, we are 
convinced that the approach of pooling data from different samples yields valid results. Still, 
to remove any offset effects of scanner, all analyses were done on the residuals after 
scanner was regressed out (see Statistical analyses). 
 
Longitudinal change was calculated by use of Quarc, previously demonstrated to be highly 
sensitive to longitudinal volumetric changes based on MRI (Holland & Dale, 2011; Holland et 
al., 2011). Two MPRAGEs at each time-point were averaged to increase the ANR and CNR. An 
increase in SNR/ CNR is expected to yield more accurate change estimates. Labeling was 
done as described in Fischl et al. (2002) with FreeSurfer 3.0.2. 
 
2.4 Statistical analyses 
To reduce the number of comparisons, mean values for left and right hemisphere were used 
in all ROI analyses. Analyses were performed on residuals after the effects of sample/ 
scanner and ICV were removed. ICV was regressed out to remove the effects of the slight 
age-differences in head size (r = -.12, p < 10-4).  
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For the cross-sectional analyses, a nonparametric local smoothing model, the smoothing 
spline, implemented in Matlab, was fitted to the data. We have previously shown that this 
approach gives less biased solutions than the more commonly employed higher-order 
polynomial functions (Fjell et al., 2010a), and that caution should be exerted in inferring 
trajectories from global fit models, e.g. the quadratic model. For instance, the peaks of 
quadratic functions will inherently depend on the age range sampled. The quadratic function 
is always a parabola, which sometimes causes the model to indicate a non-monotonous age-
relationship when non-linear but monotonous trajectories are a more likely. Also, for 
quadratic models, the second derivative is assumed to be constant across the life span, and 
hence the point of maximum acceleration of slope change cannot be determined.  
 
We used an algorithm that optimizes smoothing level based on a version of Bayesian 
Information Criterion (BIC), i.e. the smoothing level that minimizes BIC for each analysis was 
chosen. BIC offers a relative measure of amount of information lost when a model is used to 
describe a set of data, and thus describes the trade off between bias and variance in the 
construction of models. BIC rewards goodness of fit, but includes a penalty that is an 
increasing function of the number of estimated parameters. Thus, BIC attempts to find the 
model that best explains the data with a minimum of free parameters, i.e. with a largest 
possible smoothing level. With no smoothing, the smoothing spline will yield an extremely 
good apparent fit to the data, but the model would not be generalizable (over-fitting). BIC 
takes this into account by penalizing for loss of degrees of freedom. As BIC contains scaling 
constants, the absolute BIC values are irrelevant. To ease comparison of BIC between 
Ordinary Least Squares (OLS) linear models and smoothing spline models, we used ∆I, which 
10 
 
is the difference between BIC for the model and the lowest BIC - in this case, the difference 
between the smoothing spline model and the linear OLS model. As a rule of thumb, ∆I < 2 
would indicate that the two models are essentially indistinguishable with regard to goodness 
of fit, ∆I  > 4 would indicate considerable differences between the models, and ∆I > 10 would 
indicate that the linear model has essentially no support.  
 
We calculated the ages where the slope of the local smoothing curve changed (the second 
derivative), using the expression 
 
−
d2 f age( )
d age2
. We named these age-points critical ages, and 
identified zero, one or two critical ages for each brain structure.  
 
There were no clear differences in age distribution across samples (see Supplementary 
Figure 1). Still, to avoid possible bias resulting from uneven age-distribution across samples 
that could not be resolved by regressing out linear effects of sample and scanner, the main 
smoothing spline analyses were also run for the main structures in a subset of participants 
without any sample × age interaction. For each sample, an equal number of participants 
were chosen for each decade, before the data were pooled. This sample included 522 
participants, with a perfect distribution of participants across decades and samples. 
 
For the longitudinal analyses, annual percentage change was calculated for each ROI. These 
results have previously been reported (Fjell et al., 2009a), but was included to allow direct 
comparison with the cross-sectional results. Correspondence between longitudinal data and 
the smoothing spline models based on the cross-sectional data was assessed in two ways. 
First, we tested whether the structures or regions that showed increases or decreases in the 
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full cross-sectional sample also showed longitudinal increases or decreases, respectively, in 
the independent ADNI sample. Second, we tested to what extent the pattern of estimated 
change across structures was the same in the cross-sectional and the longitudinal data. 
Unfortunately, the ADNI database contains only data for the latter part of the age-range (60-
91 years), so comparisons with the cross-sectional results cannot be done throughout the 
adult life-span. Because the methods used to calculate longitudinal change and to fit the 
cross-sectional trajectories differ in important aspects, and the samples do not overlap, 
direct comparisons of estimations of absolute rates of atrophy between the longitudinal and 
cross-sectional results were not performed. Longitudinal reductions were measured as 
proportion of change between time points, and further converted to annual percentage 
volume change. Brain volumes in the cross-sectional data were regressed on sample and ICV, 
and age-reductions estimated from the cross-sectional data were measured in standard 
deviation decline in volume in the age-range 60 to 90.  
 
3. Results 
3.1 Cross-sectional data 
To compare the linear and the smoothing spline models, we calculated BIC for the 
relationship between each brain volume and age (Supplementary Table 2, also including the 
quadratic model for comparison purposes). Scatterplots illustrating the estimated 
trajectories are presented in Figure 1 (structures) and Figure 2 (ventricular system). Of the 
17 tested regions, a non-linear model represented the data best for 13 (total brain volume, 
cerebral cortex and WM, hippocampus, caudate, cerebellar WM, brain stem, pallidum, 
putamen, and lateral, inferior lateral, 3rd and 4th ventricle). The linear model showed the 
12 
 
best fit for five regions (nucleus accumbens, cerebellar cortex, amygdala, thalamus). For the 
putamen, BIC indicated that the smoothing spline model was marginally better than a linear 
model (BIC = 4.16), but deviation from linearity was minute. To test the stability of the 
results, a split half analysis was performed for WM volume (Supplementary Figure 2), 
yielding identical spline curves. 
 
Inspections of the plots revealed substantial differences in estimated trajectories for the 
non-linear models. Especially, there were large differences in curvature. For some structures, 
there was a peak or an inflection point after which the age-relationship increased in strength 
(cerebral and cerebellar WM and hippocampus, to some degree TBV and the brainstem). For 
cerebral WM was a non-monotonous, inverse U-shaped relationship observed. For other 
structures, advanced age was accompanied by reduction in estimated change (caudate and 
all ventricular cavities, to some degree cerebral cortex and pallidum). Validation analyses in 
the subset of participants perfectly distributed across decades in all samples confirmed the 
results (Supplementary Figure 3).   
 
 [Insert Figure 1 and Figure 2 about here] 
 
For the structures that showed deviations from linearity (except putamen), critical ages, i.e. 
the ages where estimated atrophy started to accelerate or decelerate, were identified. For 
some structures, one critical age was identified, while two were found for others (referred to 
as early and late critical age, see Figure 3). Early critical age varied greatly across structures, 
from 31 to 59 years, and volume-age correlations differed between the defined periods. For 
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the regions best described by a linear fit, age-correlations were as follows: amygdala r = -.56, 
putamen r = -.69, thalamus r = -.65, nucleus accumbens r = -.70 and cerebellum GM r = -.52. 
 
[Insert Figure 3 about here] 
 
3.2 Longitudinal validation 
All ROIs showed significant longitudinal change at p < .05. This confirmed the finding of 
substantial atrophy/ ventricular expansion observed cross-sectionally for all ROIs, except the 
caudate nucleus. For caudate, a weak positive correlation with age was observed after 59 
years in the cross-sectional data, which was not found in the longitudinal analyses. 
 
Next, we studied how well the pattern of cross-sectionally estimated change matched the 
longitudinal findings. In the age-range 60-90 years, Spearman ρ between the cross-sectional 
estimate of shrinkage and the longitudinally measured volume loss was .91 (p < 10-5). In the 
cross-sectional analyses, the regions with the steepest estimated decline between 60 and 90 
were cerebral WM (z = -2.20), hippocampus (z = -2.05), cerebellum WM (z = -1.29) and 
thalamus (z = -1.14). In the longitudinal analyses, the hippocampus showed the fastest 
shrinkage rate (-0.83% annually), followed by amygdala (-0.81%), thalamus (-0.69%), cerebral 
WM (-0.58%), accumbens and cerebellum WM (-0.57%), putamen (-0.43%), pallidum (-
0.40%), cerebellar cortex (-0.35%), the brainstem (-0.31%) and the caudate (-0.24%). For the 
ventricles, there was perfect overlap between the cross-sectionally and longitudinally 
estimated expansion, in that the inferior lateral ventricles (cross-sectionally estimated z = 
2.92/ vs. longitudinally estimated % annual change = 5.47) showed the largest effects, 
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followed by the lateral ventricles (z = 2.15 vs. 4.40%), the 3rd ventricle (z = 1.8 vs. 3.07%) and 
the 4th ventricle (z = 0.59 vs. 0.71%). Thus, although there was not a one-to-one 
correspondence between the pattern of change across structures from the large cross-
sectional sample and the longitudinal sample, there was still substantial overlap.   
 
4. Discussion 
There were three main findings: First, a heterogeneous pattern of discontinuous age-
correlations in different age-spans characterised the majority of brain regions, and critical 
ages for changes in estimated rates of atrophy could be identified. Second, accelerated 
estimated reduction with advanced age is not the norm of brain aging. Rather, different 
structures showed a mix of trajectories. When more negative (positive for CSF) age-volume 
correlations were seen in the last part of the age-span, this would typically start in mid-life. 
Finally, the longitudinal analyses in general supported the cross-sectional results, with a 
reasonably coherent pattern of atrophy across structures.  
 
4.1 Trajectories of estimated change across the adult life-span 
Cross-sectional studies have shown non-linear age-relationships for the volume of several 
brain structures (Raz et al., 2004, Allen et al., 2005, Lupien et al., 2007), including studies 
with samples overlapping the present (Walhovd et al., 2009). There have, however, been 
few attempts to describe the trajectories in detail (for exceptions, see (Jernigan et al., 2001b, 
Fjell et al., 2010a, Schuff et al., 2010)). We identified three basic types of trajectories: 
15 
 
(1) Linear reduction: Amygdala, putamen, thalamus, accumbens and the cerebellar cortex 
were all linearly related to age (all r’s < -.52), confirming previous findings (Gunning-Dixon et 
al., 1998, Jernigan et al., 2001a, Allen et al., 2005, Curiati et al., 2009, Walhovd et al., 2011).  
(2) Stability followed by decline: Hippocampus, the brain stem and cerebellar WM exhibited 
initial weak age-correlations, but with acceleration of estimated decline from around mid-
life. Hippocampus is especially important due to its role in memory and early AD (de Leon et 
al., 2006, Du et al., 2007, Jack et al., 2008, Fennema-Notestine et al., 2009, McEvoy et al., 
2009). Cross-sectional studies have shown prolonged development (Ostby et al., 2009) and a 
marked non-linear pattern of estimated change in adulthood (Allen et al., 2005, Jernigan and 
Gamst, 2005, Walhovd et al., 2005, Kennedy et al., 2008, Fjell et al., 2010a). We found that 
after a period of relative stability during mid-life, accelerated estimated reductions started at 
about 50 years of age, followed by a strongly negative linear age-relationship from 60 years. 
Cerebral WM was the only structure positively correlated with age in the earliest part of the 
age-range, followed by a strong negative relationship. This pattern is in line with a previous 
publication reporting multi-modal imaging data from 8-85 years, partly overlapping sample 
five (Westlye et al., 2010b). The ventricles showed modest estimated increase or slow 
decrease until 50-60 years, followed by steep estimated expansion during the last phase of 
life.  
(3) Steep, non-linear decline: Total brain volume (TBV), cerebral cortex and pallidum showed 
two critical ages with slight differences in estimated decline. TBV correlated stronger with 
age after 60 years than in the preceding life-phases (p < .05, by use of t-tests of Fisher’s z-
transformed correlations). In contrast, pallidum and the cerebral cortex correlated stronger 
with age early (p < .05).  
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Caudate was the most deviant structure, best described by a U-shaped trajectory. We advise 
to interpret this with great caution, however, as this result was not in coherence with the 
longitudinal analyses, and we have no reason to expect an increase in volume in the latter 
part of the life-span.  
 
4.2 Critical ages in estimated regional brain change 
The trajectory of a neuroanatomical volume across age represents the additive combination 
of several neurobiological processes. We suggest that changes in the relative impact of these 
can be observed as turning points in the estimated change in brain volumes, what we refer 
to as critical ages (see Figure 4). For instance, WM increases in volume well into adulthood 
(Pfefferbaum et al., 1994, Giedd, 2004, Wozniak and Lim, 2006, Westlye et al., 2010b), with 
myelination being one likely underlying factor. After mid-life, volume decreases (Allen et al., 
2005, Walhovd et al., 2011), likely partly caused by loss of small myelinated fibers and 
myelin breakdown (Meier-Ruge et al., 1992, Peters et al., 2000). This will be affected by 
medical conditions such as hypertension, cholesterol, diabetes or metabolic syndrome, 
genetic variations such as apolipoprotein E (APOE), and variables such as cognitive activity 
and education. Processes with opposite effects on WM volume probably work concurrently, 
e.g. redundant myelination (Peters et al., 2000) and fluid bubbles in the myelin sheet with 
higher age (Peters and Sethares, 2002). The relative impact of each of these processes likely 
changes across the age-span. To speculate, one scenario may be as follows: The additive 
effects of developmental processes cause the observed WM volume growth in the first half 
of the age-span. However, after a certain age, myelin breakdown and loss of small 
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myelinated fibers play increasingly important roles, likely before the developmental 
processes have come to an end. Eventually, the degenerative processes will impact the WM 
volume to such an extent that yearly growth is no longer linear, but is gradually reduced. At 
this point, the second derivative of the age-volume trajectory will change, representing a 
critical age. As such, the estimated volume of a brain structure alone reflects the sum of 
many concurrent developmental and degenerative biological processes. We believe that 
identification of turning points may add to our understanding of the trajectories of brain 
volumes across the adult life-span. The trajectory depicted in Figure 4 is meant to illustrate 
the principle of how accumulated influence of opposing factors affects volume, but is not 
intended to accurately depict the life-course of any single structure. 
 
 [Insert Figure 4 about here] 
 
The differences in the slope of the curves between the critical ages varied greatly between 
structures. While the cerebral cortex was almost linearly related to age, cerebral WM and 
the hippocampus showed large slope differences in the age-ranges on each side of the 
critical age. Although not estimated in the present study, confidence intervals for the critical 
ages will likely be larger for the more linear slopes than for the distinct non-linear and even 
non-monotonous slopes.   
 
4.3 Cross-sectional vs. longitudinal results 
It is impossible to infer changes in brain structures based on cross-sectional data alone (Raz 
and Lindenberger, 2010), as this depends on assumptions of no cohort-effects and selection 
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bias. These assumptions may generally not be valid and cross-sectional estimates of change 
diverge substantially (Raz et al., 2005), and sometimes even oppose longitudinal 
observations (Nyberg et al., 2010, Raz and Lindenberger, 2011). Therefore, longitudinal data 
from an independent sample (Fjell et al., 2009a) were included in the present paper. With 
the exception of caudate volume, the direction and statistical significance of the age-
relationships in the cross-sectional data were confirmed by the longitudinal analyses. 
Further, although far from perfect, there was a reasonably coherent relationship between 
the pattern of atrophy between cross-sectional and longitudinal results: the structures with 
the largest age-correlations in the cross-sectional material tended to show the highest rates 
of annual atrophy/ expansion. The rank-order correlation was .91. Thus, at least in their rank 
order of magnitude, the cross-sectional results for the age-range above 60 years seem to be 
largely in coherence with independent longitudinal data. 
 
Nonetheless, caution must still be exercised in interpreting the results, as longitudinal data 
were available for the oldest part of the sample only. The observed correlation between age 
and ICV indicates that cohort differences may indeed exist in the sample. Still, age accounted 
for only 1.4% of the variance in ICV, and all analyses were performed on residuals after ICV 
was regressed out. As the main determinant of ICV is the lifetime maximum size of the brain, 
ICV-corrections reduce the impact of cohort effects. Some evidence even suggests that 
cross-sectional studies may underestimate the extent of regional brain shrinkage in some 
regions (Raz et al., 2005).  
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Of more general concern is that the inherent problem of mapping life-span trajectories from 
cross-sectional examinations cannot easily be resolved with longitudinal data, since 
longitudinal examinations of brain structures over decades are not feasible, and longitudinal 
studies have methodological problems of their own (e.g. selective recruitment and attrition). 
Adding to this, most longitudinal studies are limited in age-span, sample size and number of 
follow-ups. To some degree, combined cross-sectional and longitudinal designs can alleviate 
the concerns raised above. For instance, accelerated hippocampal atrophy with age has 
been demonstrated (Raz et al., 2005, Driscoll et al., 2009, Fjell et al., 2009a, Raz et al., 2010). 
However, all of these studies except Raz et al. (2005) comprised middle-aged and elderly 
participants only, and the results thus inform us less about life-span trajectories.  
 
It is important to keep in mind that brain volumes change within relatively narrow time 
windows. As long as we do not know the true shape of these processes, it is unclear how 
many critical turning points there are in brain development and aging. An ideal approach to 
reproduce the dynamic process of change would be longitudinal studies with high density of 
measures and assessment of multiple time windows across the life span (Raz et al., 2010; 
Raz & Lindenberger, 2011). 
 
Several factors affect the estimated trajectories at the group level and the actual trajectories 
at the individual level. These include genetic variations such as APOE, and medical factors 
such as hypertension, cholesterol and diabetes (for a review, see e.g. Raz et al., 2012). In 
addition, cognitive activity or training may impact brain structure even in older age (Zatorre 
et al., 2012). Future studies should further explore the impact and interactions between 
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genetic, environmental and medical factors on brain structure throughout the adult life. 
More knowledge about these processes will increase our understanding of normal brain 
aging. Also, possible influence of pre-symptomatic Alzheimer’s disease (AD) can be difficult 
to disentangle from normal age-changes in the older participants, as follow-up examinations 
over several years are necessary to exclude subjects with incipient disease. However, while 
this factor is difficult to completely rule out from the present results, there are indications 
that this is not likely to have affected the trajectories to a substantial degree. Even though 
hippocampal volume is the structure that distinguishes best between AD-patients and 
healthy elderly, amygdala is also affected in early stages of the disease (Fjell et al., 2010b). 
While the age-slope for hippocampus is much steeper after 60 years, this is not seen for 
amygdala, which would be expected if incipient AD was a major factor in shaping the 
estimated trajectories. Even if a few of the participants had incipient AD and consequently 
abnormal volume decline in select structures, the smoothing spline approach is relatively 
robust to the influence of outliers as long as the sample size is large. 
 
4.4 Conclusion 
The present study shows that the majority of brain structures follow complex, non-linear 
volumetric trajectories through adult life. Important next step to increased understanding of 
the mechanisms of brain aging will be to conduct large-scale, multi-modal imaging studies, 
combining e.g. volumetry, DTI and intensity/contrast measures (Fjell et al., 2008, Westlye et 
al., 2010b, a), as well as longitudinal studies with high density of measurements to examine 
the trajectories across age with regards to the critical phases proposed on the basis of the 
cross-sectional analyses.  
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Figure legends 
 
Figure 1 Scatterplots of age-brain structure relationships 
The figure shows the individual data points and the cross-sectionally estimated trajectories 
for the 13 brain structures of interest based on the smoothing spline. Y-axis values represent 
mean volume across hemispheres, corrected for the influence of sample and intracranial 
volume (Z-scores). The right bottom figure shows some of the segmented structures of the 
average brain of Sample 2. The three-dimensional renderings illustrate the average shape, 
extension and relative position within the brain. The cerebral cortex and underlying white 
matter are made transparent to allow visualization of the underlying subcortical structures. 
 
Figure 2 Scatterplots of age - ventricular system relationships 
The figure shows the individual data points and the cross-sectionally estimated trajectories 
for the ventricles based on the smoothing spline. Y-axis values represent mean volume 
across hemispheres, corrected for the influence of sample and intracranial volume (Z-
scores). 
 
Figure 3 Estimated age-trajectories and critical ages 
The figure shows the estimated age-trajectories from the cross-sectional analyses for the 12 
areas that deviated from linearity, based on the smoothing spline. Critical ages, identified by 
changes in the second derivative, are displayed. Pearson correlations between brain volume 
and age are shown for each age phase separated by the critical ages. All correlations were 
significant at p < .05, except for pallidum in middle age (.01), cerebellum WM in young age (-
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.02) and brain stem in young age (.01). Due to small age-variance, correlations are not 
presented for age-phases defined by critical ages of 80 years or higher. Critical ages are 
indicative of phases where estimated changes in brain volumes are in transitions. 
 
Figure 4 A hypothetic model for discontinuous change in rate of atrophy 
The figure represents a simplified attempt to visualize how two sets of age-dependent 
degenerative effects can affect the age-trajectory of a brain volume, and how timing of 
critical ages reflect the start and endpoint of these effects. The blue line represents the 
volume of a brain structure through life, e.g. WM volume. In the first part of life, volume 
increases, caused by the sum of progressive events, e.g. myelination and axonal growth 
(green line). Before the maturational changes caused by the progressive events have come 
to an end, degenerative events starts, e.g. selective loss of small-diameter myelinated axons 
(primary degenerative event) and demyelination of larger connections (secondary 
degenerative event). The onset of these processes will affect the growth rate of the curve, 
detected as a change in the second derivative, and this change can be termed early critical 
age. After this point, the volume increase slowly decelerates. After continuous impact on the 
volume from these two processes, one of them eventually burns out in higher age while the 
other continues further. This causes a late critical age, where the volume reductions slowly 
starts to level off. This is of course a gross simplification of the processes in the brain and the 
trajectories that may characterize them. The main point is to illustrate that critical ages may 
be used in the characterisation of estimated age-trajectories of brain volumes, and that they 
may be related to underlying neurobiological events, both developmental and degenerative.  
 




 Sample Country N 
(% f) 
Age 
mean 
(range) 
Education 
mean 
(range) 
Key 
publications 
Main screening 
instruments/ 
inclusion criteria 
1 Norway 69 
(57) 
51.3 
(20-88) 
15 
(7-20) 
(Walhovd et al., 
2005a) 
Health interview, 
MMSE > 26, BDI < 
16, IQ > 85, RH only 
2 Norway 208 
(71) 
 
46.8 
(19-75) 
14 
(9-22) 
(Espeseth et al., 
2008) 
Health interview, IQ 
> 85 
3 USA 309 
(63) 
44.5 
(18-94) 
3.5 
(1-5)c 
(Marcus et al., 
2007) 
Health interview, 
CDR = 0b, MMSE > 
25b, RH only 
4 USA 191 
(60) 
47.3 
(18-81) 
15.7 
(12-21) 
(Raz et al., 
2004a) 
Health interview, 
BIMCT > 30, GDQ < 
15, RH only, 
neuroradiology, 
5 Norway 323 
(57) 
50.8 
(20-85) 
15.6e 
(4-26) 
(Fjell et al., 
2010; Westlye 
et al., 2010) 
Health interview, 
Neuropsychological 
evaluation, BDI < 16, 
IQ > 85, RH only 
Nor: Norway 
% f: percentage of female participants 
MMSE: Mini Mental Status Exam (Folstein et al. 1975) 
BDI: Beck Depression Inventory (Beck, 1987) 
BIMCT: Blessed Information-Memory-Concentration Test (Blessed et al. 1968) 
CDR: Clinical Dementia Rating (Berg, 1984, 1988; Morris, 1993) 
GDQ: Geriatric Depression Questionnaire (Auer and Reisberg, 1997) 
RH: Right handed 
WASI: Wechsler Abbreviated Scale of Intelligence (Wechsler, 1999) 
a Available for 70 participants 
b Available for participants > 60 years only 
c Available for all participants > 60 years, and sporadically for the rest. 1: less than high 
school grad., 2: high school grad., 3: some college, 4: college grad., 5: beyond college 
d Alzheimer patients 
e Missing for four participant 
Table 1 Sample characteristics cross-sectional sample 
 
 
Structure Linear 
 
BIC 
Quadratic 
 
BIC 
Smoothing 
spline 
BIC 
Linear vs 
smoothing 
∆ BIC 
Total Brain Volume 32165.77 32142.15 32134.01 31.76 
Cerebral cortex 32006.13 31984.60 31980.57 25.56 
Cerebral WM 7548.20 7370.2 7360.08 188.12 
Hippocampus 7327.24 7227.79 7226.24 101 
Amygdala 7302.48 7301.69 7301.17 1.31 
Pallidum 7301.54 7298.56 7289.19 12.35 
Caudate 7623.18 7564.97 7570.50 52.68 
Putamen 6999.88 6996.99 6995.72 4.16 
Thalamus 7105.95 7104.36 7103.14 2.81 
Accumbens 6981.52 6988.51 6981.56 -0.04 
Brain stem 33020.28 33001.76 33003.99 16.29 
Cerebellum cortex 7362.42 7369.39 7362.46 -0.04 
Cerebellum WM 7594.55 7548.38 7550.45 44.1 
Ventricles     
Lateral ventricles 7145.50 7015.81 7011.87 133.63 
Inf Lat Vent 32636.83 32424.91 32385.02 251.81 
3rd ventricle 32502.03 32386.94 32387.29 114.74 
4th ventricle 33024.24 33006.05 33007.41 16.83 
 
Table 2 Testing of linearity 
∆ BIC > 4 indicates that the smoothing spline modell yield a better account of the data than 
the linear modell, while BIC < 4 indicates that a liner fit to the data are the most appropriate. 
BIC values for the quadratic model are included for comparison purposes. 
Bold indicates BIC < 4 
BIC: Bayesian Information Criterion 
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Supplemental Table 1 Sample characteristics cross-sectional sample 
 
Structure Linear 
 
BIC 
Smoothing 
spline 
BIC 
Linear vs 
smoothing 
∆ BIC 
Total Brain Volume 32166 32134 32 
Cerebral cortex 32006 31981 25 
Cerebral WM 7548 7360 188 
Hippocampus 7327 7226 101 
Amygdala 7302 7301 1 
Pallidum 7302 7289 13 
Caudate 7623 7571 52 
Putamen 7000 6996 4 
Thalamus 7106 7103 3 
Accumbens 6982 6982 0 
Brain stem 33020 33004 16 
Cerebellum cortex 7362 7362 0 
Cerebellum WM 7595 7550 44 
Ventricles    
Lateral ventricles 7146 7012 134 
Inf Lat Vent 32637 32385 252 
3rd ventricle 32502 32387 115 
4th ventricle 33024 33007 17 
 
Supplemental Table 2 Testing of linearity 
∆ BIC > 4 indicates that the smoothing spline model yield a better account of the data than 
the linear model, while BIC < 4 indicates that a linear fit to the data are the most 
appropriate.  
Bold indicates ∆BIC > 4 
BIC: Bayesian Information Criterion 
 
 
 
 
